Related Experiment Video
Updated: Jul 9, 2026

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis
Published on: February 16, 2015
Nuclear survivin has reduced stability and is not cytoprotective
Claire M Connell1, Rita Colnaghi1, Sally P Wheatley1
1Genome Damage and Stability Centre, University of Sussex, Falmer, Brighton BN1 9RQ, United Kingdom.
Abstract:
Survivin is an essential mitotic protein that is overexpressed in many cancers, and its presence is correlated with increased resistance to radiation and chemotherapy. Here we demonstrate that sending survivin into the nucleus accelerates its degradation in a cdh1-dependent manner, abolishes the radio resistance normally conferred to cells by its overexpression, and prevents survivin from inhibiting apoptosis without affecting its mitotic localization. Our data suggest that targeting survivin to the nucleus provides an efficient means of eliminating it from the cell and may prove a novel strategy in cancer treatment, particularly in combination with radiotherapy.
Insights
Targeting the survivin protein to the nucleus accelerates its degradation, reducing cancer cell resistance to radiation and chemotherapy. This nuclear targeting may offer a novel cancer treatment strategy, especially when combined with radiotherapy.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Survivin is a key mitotic protein frequently overexpressed in various cancers.
- Elevated survivin levels correlate with enhanced resistance to radiation and chemotherapy.
- Survivin's overexpression contributes to radioresistance and inhibits apoptosis.
Purpose of the Study:
- To investigate the effect of nuclear localization on survivin stability and function.
- To determine if targeting survivin to the nucleus can overcome cancer cell resistance.
- To explore the potential of nuclear survivin targeting as a cancer therapy strategy.
Main Methods:
- Demonstrated nuclear import of survivin.
- Assessed survivin degradation in a cdh1-dependent manner.
- Evaluated the impact on radioresistance and apoptosis inhibition.
- Analyzed survivin's mitotic localization.
Main Results:
- Nuclear import of survivin accelerates its degradation via a cdh1-dependent pathway.
- Targeting survivin to the nucleus abolished the radioresistance conferred by its overexpression.
- Nuclear survivin targeting prevented apoptosis inhibition without altering its mitotic localization.
Conclusions:
- Directing survivin to the nucleus enhances its cellular elimination.
- This strategy effectively overcomes survivin-mediated radioresistance and apoptosis resistance.
- Nuclear survivin targeting represents a promising novel approach for cancer treatment, particularly in conjunction with radiotherapy.
Related Concept Videos
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
Nuclear Stability
To hold positively charged protons together in the...
Nuclear Export
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle

